Upregulation of long‑noncoding RNA PTPRG‑AS1 can predict the poor prognosis and promote migration and invasion in patients with osteosarcoma

Ge,Rile; Yang,Peng; Wen,Bingtao

doi:10.3892/ol.2021.12725

Upregulation of long‑noncoding RNA PTPRG‑AS1 can predict the poor prognosis and promote migration and invasion in patients with osteosarcoma

Authors:
- Rile Ge
- Peng Yang
- Bingtao Wen
View Affiliations

Affiliations: Department of Orthopedics, Peking University International Hospital, Haidian, Beijing 102206, P.R. China
Published online on: April 12, 2021 https://doi.org/10.3892/ol.2021.12725
Article Number: 464
Copyright: © Ge et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to determine the expression of the long non‑coding RNA PTPRG‑AS1 in patients with osteosarcoma, and to explore its role on the prognosis of patients and the process of osteosarcoma cell metastasis. Reverse transcription quantitative‑PCR was performed to detect PTPRG‑AS1 expression in osteosarcoma tumor tissues and cells (U2OS, SJSA1 and Saos‑2), and normal tissues and cells (hFOB1.19). In addition, qPCR and western blotting were also used to detect mRNA and protein expression, respectively, whereas fluorescence in situ hybridization was used to locate the position of PTPRG‑AS1 in osteosarcoma cells. Transwell assay was used to determine the migratory and invasive abilities of osteosarcoma cells. The results demonstrated that PTPRG‑AS1 was highly expressed in osteosarcoma cells and tissues, which was compared with normal bone cells and adjacent healthy tissues. Furthermore, PTPRG‑AS1 expression level in patients with osteosarcoma and lymph node metastasis or distal metastasis was elevated compared with normal tissues. In addition, the results from univariate and multivariate analyses demonstrated that PTPRG‑AS1 expression level was significantly associated with Tumor‑Node‑Metastasis stage (P=0.025), lymph node metastasis (P=0.035) and distant metastasis (P=0.016) in patients with osteosarcoma. PTPRG‑AS1 expression level (odd ratio, 3.012; 95% confidence interval, 1.564‑4.219) was also considered as an independent risk factor affecting the 5‑year survival rate of patients with osteosarcoma. Furthermore, the 5‑year overall survival rate of patients with elevated PTPRG‑AS1 expression level (56.36%) was significantly lower compared with patients with low PTPRG‑AS1 expression level (78.43%). In addition, PTPRG‑AS1 knockdown using small interfering RNA significantly decreased the invasive and migratory abilities of osteosarcoma cells in vitro. In summary, PTPRG‑AS1 high expression in patients with osteosarcoma may predict the poor prognosis of patients, as PTPRG‑AS may have a promoting effect on osteosarcoma cell metastasis.

View Figures

View References

1	Ottaviani G and Jaffe N: The epidemiology of osteosarcoma. Pediatric and Adolescent Osteosarcoma. Springer; pp. 3–13. 2009, View Article : Google Scholar
2	Lindsey BA, Markel JE and Kleinerman ES: Osteosarcoma Overview. Rheumatol Ther. 4:25–43. 2017. View Article : Google Scholar : PubMed/NCBI
3	Harrison DJ, Geller DS, Gill JD, Lewis VO and Gorlick R: Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 18:39–50. 2018. View Article : Google Scholar : PubMed/NCBI
4	Anderson ME: Update on survival in osteosarcoma. Orthop Clin North Am. 47:283–292. 2016. View Article : Google Scholar : PubMed/NCBI
5	Wang DQ, Fu P, Yao C, Zhu LS, Hou TY, Chen JG, Lu Y, Liu D and Zhu LQ: Long non-coding RNAs, novel culprits, or bodyguards in neurodegenerative diseases. Mol Ther Nucleic Acids. 10:269–276. 2018. View Article : Google Scholar : PubMed/NCBI
6	Niu ZS, Niu XJ and Wang WH: Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications. World J Gastroenterol. 23:5860–5874. 2017. View Article : Google Scholar : PubMed/NCBI
7	Tehrani SS, Karimian A, Parsian H, Majidinia M and Yousefi B: Multiple functions of long non-coding RNAs in oxidative stress, DNA damage response and cancer progression. J Cell Biochem. 119:223–236. 2018. View Article : Google Scholar : PubMed/NCBI
8	Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A and Ghafouri-Fard S: Expression analysis of four long noncoding RNAs in breast cancer. Tumour Biol. 37:2933–2940. 2016. View Article : Google Scholar : PubMed/NCBI
9	Yang X, Yan M, Chengjiang W, et al: Analysis of LncRNAs and mRNAs expression profiles in ovarian epithelial cancer cell lines by gene microarray. Chinese Journal of Clinical Laboratory Science. 36:384–387,400. 2018.PubMed/NCBI
10	Xu C, Li Z, He T, Yuan B and Ding B: Long noncoding RNA PTPRG-AS1 regulates growth of glioma cells by sponging miR-185-5p. RSC Advances. 9:10870–10880. 2019. View Article : Google Scholar
11	Yi L, Ouyang L, Wang S, Li SS and Yang XM: Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1. J Cell Physiol. 234:19088–19102. 2019. View Article : Google Scholar : PubMed/NCBI
12	Cates JM: Comparison of the AJCC, MSTS, and modified spanier systems for clinical and pathologic staging of osteosarcoma. Am J Surg Pathol. 41:405–413. 2017. View Article : Google Scholar : PubMed/NCBI
13	Laurini JA and Cooper K: Pathologic staging of bone and soft tissue tumors: What is new in the eighth edition of the American Joint Committee on Cancer Staging Manual? AJSP. 23:149–156. 2018.
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Chen ZZ, Huang L, Wu YH, Zhai WJ, Zhu PP and Gao YF: LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression. Nat Commun. 7:125982016. View Article : Google Scholar : PubMed/NCBI
16	Zhuang J, Huang Y, Zheng W, Yang S, Zhu G, Wang J, Lin X and Ye J: TMEM100 expression suppresses metastasis and enhances sensitivity to chemotherapy in gastric cancer. Biol Chem. 401:285–296. 2020. View Article : Google Scholar : PubMed/NCBI
17	Mumprecht V and Detmar M: Lymphangiogenesis and cancer metastasis. J Cell Mol Med. 13:1405–1416. 2009. View Article : Google Scholar : PubMed/NCBI
18	Su Z, Yang Z, Xu Y, Chen Y and Yu Q: Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 14:482015. View Article : Google Scholar : PubMed/NCBI
19	Yang J and Zhang W: New molecular insights into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406. 2013. View Article : Google Scholar : PubMed/NCBI
20	Sun XH, Yang LB, Geng XL, Wang R and Zhang ZC: Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma. Int J Clin Exp Pathol. 8:2994–3000. 2015.PubMed/NCBI
21	Zhao H, Hou W, Tao J, Zhao Y, Wan G, Ma C and Xu H: Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/β-catenin signaling pathway. Am J Transl Res. 8:3503–3512. 2016.PubMed/NCBI
22	Zhou S, Yu L, Xiong M and Dai G: LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. Biochem Biophys Res Commun. 495:1822–1832. 2018. View Article : Google Scholar : PubMed/NCBI
23	Wang Y and Kong D: LncRNA GAS5 represses osteosarcoma cells growth and metastasis via sponging MiR-203a. Cell Physiol Biochem. 45:844–855. 2018. View Article : Google Scholar : PubMed/NCBI
24	Liu G, Wang L, Han H, Li Y, Lu S, Li T and Cheng C: LncRNA ZFAS1 promotes growth and metastasis by regulating BMI1 and ZEB2 in osteosarcoma. Am J Cancer Res. 7:1450–1462. 2017.PubMed/NCBI
25	Dong Y, Liang G, Yuan B, Yang C, Gao R and Zhou X: MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol. 36:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI
26	Valastyan S and Weinberg RA: Tumor metastasis: Molecular insights and evolving paradigms. Cell. 147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
27	Steeg PS: Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med. 12:895–904. 2006. View Article : Google Scholar : PubMed/NCBI
28	Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
29	Yang J and Weinberg RA: Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
30	Radisky DC: Epithelial-mesenchymal transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
31	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI
32	Gonzalez DM and Medici D: Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 7:re8. 2014. View Article : Google Scholar : PubMed/NCBI
33	Korpal M, Lee ES, Hu G and Kang Y: The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
34	Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
35	Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I and Takata T: N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol. 26:147–156. 2011.PubMed/NCBI
36	Radisky ES and Radisky DC: Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010. View Article : Google Scholar : PubMed/NCBI
37	Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: An overview. Front Biosci. 11:1696–1701. 2006. View Article : Google Scholar : PubMed/NCBI